Related Experiment Video
Updated: May 14, 2026
09:14
High efficiency, Site-specific Transfection of Adherent Cells with siRNA Using Microelectrode Arrays (MEA)
Published on: September 13, 2012
A transfection method for short interfering RNA with the lipid-like self-assembling nanotube, A6K
Daizo Yoshida1, K Kim, I Takumi
1Department of Neurosurgery, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan. dyoshida@nms.ac.jp
Medical Molecular Morphology
|February 6, 2013
Summary
A novel peptide nanotube, A6K, offers a stable and effective method for delivering short interfering RNA (siRNA) into glioblastoma cells. This new technique demonstrates lower cytotoxicity compared to traditional reagents, improving gene silencing efficiency.
Area of Science:
- Biotechnology
- Molecular Biology
- Nanotechnology
Background:
- Short interfering RNA (siRNA) is crucial for gene silencing, but efficient and safe delivery remains a challenge.
- Conventional cationic transfectants like siFECTOR and Lipofectamine 2000 can exhibit significant cytotoxicity.
- Developing novel, less toxic delivery systems is essential for advancing RNA interference (RNAi) therapeutics.
Purpose of the Study:
- To develop and evaluate a novel transfection method for siRNA using a self-assembling peptide nanotube, A6K.
- To compare the cytotoxicity and transfection efficiency of A6K with established reagents (siFECTOR, Lipofectamine 2000).
- To assess the gene silencing efficacy of A6K-mediated siRNA delivery targeting MMP-2 mRNA.
Main Methods:
- A6K peptide nanotube was synthesized and characterized.
- Cytotoxicity was assessed using the MTS assay on human glioblastoma cell lines (U87MG, A172, T98G).
- Transfection efficiency was evaluated using FITC-labeled siRNA and MMP-2 mRNA expression was quantified via real-time RT-PCR.
Main Results:
- A6K exhibited significantly lower cytotoxicity in U87MG cells compared to siFECTOR and Lipofectamine 2000.
- siRNA transfection efficiency increased in a dose- and time-dependent manner with A6K.
- A6K-mediated delivery effectively reduced MMP-2 mRNA expression in a dose-dependent manner.
- Electron microscopy revealed A6K forms micelle structures with siRNA, with the peptide's hydrophilic tail associated with the siRNA.
Conclusions:
- The A6K peptide nanotube represents a novel, stable, and low-cytotoxicity method for siRNA delivery.
- This peptide-based system shows promise for enhancing RNA interference applications in cancer research and therapy.
- A6K offers a safer alternative to conventional transfection reagents, potentially improving therapeutic outcomes.
Related Concept Videos
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...